Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's Disease.
Gibson LL, Pollak TA, Hart M, Heslegrave A, Hye A, Church AJ, Lakdawala N, Nicholson TR, Batzu L, Rota S, Trivedi D, Zetterberg H, Chaudhuri KR, Aarsland D. Gibson LL, et al. Among authors: aarsland d. J Neuropsychiatry Clin Neurosci. 2023 Summer;35(3):236-243. doi: 10.1176/appi.neuropsych.20220107. Epub 2023 Jan 30. J Neuropsychiatry Clin Neurosci. 2023. PMID: 36710627
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K. Mattsson N, et al. Among authors: aarsland d. JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.
Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, Mulugeta E. Alves G, et al. Among authors: aarsland d. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1080-6. doi: 10.1136/jnnp.2009.199950. Epub 2010 Jun 14. J Neurol Neurosurg Psychiatry. 2010. PMID: 20547614
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
Mulugeta E, Londos E, Ballard C, Alves G, Zetterberg H, Blennow K, Skogseth R, Minthon L, Aarsland D. Mulugeta E, et al. Among authors: aarsland d. J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):160-4. doi: 10.1136/jnnp.2009.199398. Epub 2010 Nov 3. J Neurol Neurosurg Psychiatry. 2011. PMID: 21047883
Nonmotor symptoms of Parkinson's disease.
Rektorova I, Aarsland D, Chaudhuri KR, Strafella AP. Rektorova I, et al. Among authors: aarsland d. Parkinsons Dis. 2011;2011:351461. doi: 10.4061/2011/351461. Epub 2012 Mar 22. Parkinsons Dis. 2011. PMID: 22548200 Free PMC article. No abstract available.
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R, Larsen JP. Alves G, et al. Among authors: aarsland d. J Neurol Neurosurg Psychiatry. 2013 May;84(5):537-43. doi: 10.1136/jnnp-2012-303808. Epub 2012 Oct 31. J Neurol Neurosurg Psychiatry. 2013. PMID: 23117496
The psychosis spectrum in Parkinson disease.
Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D. Ffytche DH, et al. Among authors: aarsland d. Nat Rev Neurol. 2017 Feb;13(2):81-95. doi: 10.1038/nrneurol.2016.200. Epub 2017 Jan 20. Nat Rev Neurol. 2017. PMID: 28106066 Free PMC article. Review.
Cognitive decline in Parkinson disease.
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Aarsland D, et al. Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3. Nat Rev Neurol. 2017. PMID: 28257128 Free PMC article. Review.
679 results